Profound Medical Corp. (PROF) Earnings History
Net Loss12 years of earnings data (2014–2025) · Currently unprofitable on a TTM basis
Loading earnings history...
Profound Medical Corp. (PROF) Earnings Overview
As of June 22, 2026, Profound Medical Corp. (PROF) reported trailing twelve-month net income of -$39M, reflecting -33.6% year-over-year growth. The company earned $-1.07 per diluted share over the past four quarters, with a net profit margin of -264.4%.
Looking at the long-term picture, PROF's historical earnings data spans multiple years. The company achieved its highest annual net income of -$8M in fiscal 2014.
Profound Medical Corp. is currently reporting a net loss, though operating performance should be evaluated in the context of growth investments and industry dynamics View revenue history →
Compared to peers including ISRG ($2.98B net income, 28.4% margin), NVCR (-$173M net income, -20.8% margin), AEYE (-$4M net income, -7.6% margin), PROF has room to improve margins relative to the peer group. Compare PROF vs ISRG →
PROF Earnings vs Peers
Earnings metrics vs comparable public companies
PROF Historical Earnings Data (2014–2025)
12 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | -$43M | -60.8% | -$41M | $-1.43 | -264.4% | -256.3% |
| 2024 | -$26M | +7.3% | -$31M | $-1.07 | -260.4% | -309.6% |
| 2023 | -$29M | +0.3% | -$29M | $-1.35 | -396.8% | -397.5% |
| 2022 | -$29M | +6.6% | -$32M | $-1.38 | -429.1% | -480.9% |
| 2021 | -$31M | -42.0% | -$30M | $-1.50 | -446.7% | -440.7% |
| 2020 | -$22M | -42.0% | -$19M | $-1.25 | -296.0% | -258.3% |
| 2019 | -$15M | +0.1% | -$15M | $-1.39 | -364.7% | -357.1% |
| 2018 | -$15M | -1.8% | -$15M | $-1.52 | -797.9% | -776.0% |
| 2017 | -$15M | -23.2% | -$18M | $-2.44 | -383.8% | -451.9% |
| 2016 | -$12M | -2.9% | -$16M | $-2.93 | - | - |
| 2015 | -$12M | -43.8% | -$11M | $-4.98 | - | - |
| 2014 | -$8M | - | -$4M | $-37.86 | - | - |
Download Data
Export PROF earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
12+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PROF — Frequently Asked Questions
Quick answers to the most common questions about buying PROF stock.
What is PROF earnings per share (EPS)?
PROF trailing twelve-month (TTM) diluted EPS is $-1.07, reflecting -33.6% year-over-year growth. The 5-year EPS CAGR is N/A. Complete EPS history from 2014 to 2025 is available in the table on this page.
What is Profound Medical Corp.'s net income?
Profound Medical Corp. (PROF) trailing twelve-month net income is $-39M as of 2025. Earnings declined -33.6% year-over-year.
Is PROF profitable?
PROF is not currently profitable on a TTM basis, reporting a net loss of $-39M. Net margin is -264.4%. Investors should monitor for a return to profitability.
What is PROF's earnings growth rate?
PROF compound annual EPS growth rates (CAGR): 1-Year: N/A, 3-Year: N/A, 5-Year: N/A, 10-Year: N/A. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2014 to 2025.
What are PROF's profit margins?
Profound Medical Corp. net profit margin is -264.4%, operating margin is -256.3%, and gross margin is +70.8%. Below-average margins reflect competitive or cost pressures. Return on Equity is -56.2%.
Is PROF growing earnings?
PROF earnings are declining — EPS fell -33.6% year-over-year. TTM net income dropped to $-39M. This contrasts with the 5-year CAGR of N/A.
What was PROF's best earnings year?
Profound Medical Corp.'s highest annual net income on record is $-8M, achieved in fiscal year 2014. Earnings history on this page spans 2014 to 2025 and includes all annual and quarterly figures.
What were PROF's earnings last quarter?
PROF's most recent reported quarter was Q1 2026. Net income was $-7M with diluted EPS of $-0.19. For a full breakdown of all quarters, see the quarterly earnings table on this page.